Track Record of Identifying Rare Wealth CreatorsTrack Record of Identifying Rare Wealth Creators
Manish Goel - SEBI Registered Investment Adviser

About Manish Goel

SEBI Registered Investment Adviser • Chartered Accountant

423 Articles Published

Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

May 4, 2026
Hero header announcing Walter Schloss’s 16 Factors with a two-by-two grid of panels labeled Trader, Compounder, Drift, and Speculator.

Walter Schloss’s 16 Factors: How Graham’s Quietest Disciple Beat the Market for 47 Years Without Ever Meeting Management

Walter Schloss compounded 16% for 47 years from a back office, with no MBA, no Bloomberg terminal, and no management visits. Seven of his 16 factors illustrated through Titan Biotech FY25's audited balance sheet.
May 3, 2026
Hero section with title 'Outside View vs Inside View' and subtitle; below is a 2x2 color grid labeled: top-left 'Lucky', top-right 'Discipined Investor', bottom-left 'Confused', bottom-right 'Bias-Trapped'.

Outside View vs Inside View: Kahneman & Lovallo’s Reference-Class Forecasting Discipline

Daniel Kahneman and Dan Lovallo's 1993 distinction between the Inside View (story-driven) and the Outside View (reference-class base rates) is the most powerful behavioural upgrade an Indian long-term investor can make. We illustrate it with Titan Biotech's FY25 audited numbers, presented strictly as an educational case study of management process — not a valuation call.
May 3, 2026
Infographic titled 'Beneish M-Score' showing yearly bar chart (FY20–FY25) with scores: 3.2, 2.8, 2.1, 1.6, 1.3, 1.1 (green FY25 bar).

Beneish M-Score: The 8-Variable Forensic Model That Caught Enron Three Years Before Bankruptcy

The Beneish M-Score is the 8-variable forensic-accounting model published in 1999 that flagged Enron in 1998 — three years before bankruptcy. Learn how to compute it from any Indian annual report, and see why Titan Biotech FY25's 103% CFO/Operating Profit, ₹3 Cr borrowings, ₹7.78 Cr contingent liabilities and 14 board meetings sit deep in the 'unlikely manipulator' zone.
May 3, 2026
Hero section with title 'The Twenty-Punch-Card Rule' and a four-color grid labeled Trader (gray), Compounder (green), Drift (light gray), Speculator (orange).

The Twenty-Punch-Card Rule: Warren Buffett’s Lifetime-Scarcity Discipline for Indian Value Investors

Buffett's twenty-slot punch card forces selectivity, patience and conviction in a single mental model. Titan Biotech's FY25 audited numbers — debt-to-equity 0.02x, ~16.9% RoCE, 103% CFO/operating profit, 55.87% promoter holding — illustrate the discipline.
+91-7380122211